Sign inJoin waitlistJoin the waitlist

RI

Robert Iannone

Pediatrics / Pediatric Hematology-Oncology

Credentials: ·

History

Pediatrics

Research

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
The Lancet · 2014 · 1,497 citations
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
New England Journal of Medicine · 2019 · 702 citations
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Clinical Cancer Research · 2015 · 699 citations

EF
Ephraim Fuchs
5 papers
JC
James Casella
4 papers
KG
Keith Gottesdiener
3 papers
Leo Luznik
3 papers
Adil Daud
2 papers
AP
Amita Patnaik
2 papers
Elizabeth Raetz
2 papers
EA
Etsuko Aoki
2 papers
Lewis Silverman
2 papers
Luke Maese
2 papers
Mignon Loh
2 papers
Nancy Bunin
2 papers